The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prediction of exemestane benefit in patients with advanced breast cancer based on diagnostic biopsy mRNA analysis.
 
Troels Dreier Christensen
No Relationships to Disclose
 
Anna Sofie Kappel Buhl
Stock and Other Ownership Interests - Medical Prognosis Institute
Honoraria - Medical Prognosis Institute
 
Ib Jarle Christensen
Employment - Medical Prognosis Institute
 
Knud Mejer Nelausen
No Relationships to Disclose
 
Eva Balslev
No Relationships to Disclose
 
Ann Søegaard Knoop
Consulting or Advisory Role - Novartis; Pierre Fabre; Roche
Research Funding - Novartis (Inst)
Travel, Accommodations, Expenses - Novartis; Pierre Fabre; Roche
 
Eva Harder Brix
No Relationships to Disclose
 
Peter Michael Vestlev
Stock and Other Ownership Interests - Novo Nordisk
Consulting or Advisory Role - Oncology Venture
Research Funding - AstraZeneca; Merck KGaA; Puma Biotechnology
 
Bent Ejlertsen
Research Funding - NanoString Technologies (Inst); Novartis (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Celgene
 
Iben Kumler
Travel, Accommodations, Expenses - Roche
 
Adam Luczak
No Relationships to Disclose
 
Sven Tyge Langkjer
Research Funding - Pierre Fabre (Inst)
 
Soeren Linnet
No Relationships to Disclose
 
Erik Jakobsen
Travel, Accommodations, Expenses - Celgene; Roche
 
Jurij Antonovic Bogovic
No Relationships to Disclose
 
Vesna Glavicic
No Relationships to Disclose
 
Ulla Hald Buhl
Employment - Medical Prognosis Institute; Medical Prognosis Institute (I)
Leadership - Medical Prognosis Institute; Medical Prognosis Institute (I)
Stock and Other Ownership Interests - Medical Prognosis Institute; Medical Prognosis Institute (I)
 
Peter Buhl Jensen
Employment - Medical Prognosis Institute; Oncology Venture
Leadership - Medical Prognosis Institute; Oncology Venture
Stock and Other Ownership Interests - Medical Prognosis Institute; Oncology Venture
 
Steen Knudsen
Employment - Medical Prognosis Institute
Leadership - Medical Prognosis Institute
Stock and Other Ownership Interests - Medical Prognosis Institute
 
Dorte Nielsen
Employment - Novo Nordisk
Research Funding - Genmab; Merck KGaA